Lantus Insulin Program

Links shared publicly online about this topic

Halozyme Begins Clinical Trial To Compare Three Insulin Analogs And Provides Update On Ultrafast Insulin Program

medicalnewstoday.com — “Halozyme therapeutics, inc. (nasdaq:halo) announced the commencement of a phase 1 clinical study that will assess the effects of three approved prandial (mealtime) insulin analogs administered witView full resource at medicalnewstoday.com

  • View Related
  • Share

Most Recently Shared on September 30, 2009 at 10:42 am By:

mnt_diabetes MNT Diabetes News Health News

Halozyme Begins Clinical Trial To Compare Three Insulin Analogs And Provides Update On Ultrafast Insulin Progra.. http://bit.ly/mUOpR

4 years ago...

Pfizer scraps insulin deal with India's Biocon - Yahoo! News

news.yahoo.com — “From Yahoo! News: MUMBAI (Reuters) - Pfizer Inc, the world's largest drugmaker, has scrapped a deal to sell insulin products made by Biocon Ltd, leaving India's biggest biotechnology company without a partner to sell the drugs in key markets such as the United States. Pfizer cited other priorities in its biosimilar program for the split, which immediately ends a relationship that stood to earn Biocon hundreds of millions of dollars in royalties. Shares of Biocon fell 6.3 percent. ...View full resource at news.yahoo.com

  • View Related
  • Share

Most Recently Shared on March 13, 2012 at 3:35 am By:

HealthTrendster HealthTrendster Health Executive

Pfizer scraps insulin deal with India's Biocon - (Reuters) - Drugmaker Pfizer said on Monday it has scrapped a deal ... http://t.co/TSjPROke

1 year ago...

Biodel wins SBIR grant to develop concentrated ultra-rapid-acting insulin formulations - Pharmaceutical Business Review

contractresearch.pharmaceutical-business-review.com — “Biodel has won a two-year grant from the Small Business Innovation Research (SBIR) program of the National Institutes of Health (NIH) to develop conceView full resource at contractresearch.pharmaceutical-business-review.com

  • View Related
  • Share

Most Recently Shared on July 28, 2012 at 6:50 pm By:

sstrumello Scott Strumello Patient Expert

Biodel wins SBIR grant to develop concentrated ultra-rapid-acting insulin formulations http://t.co/azB8ZB9w

10 months ago...

The Top 3 resources shared on this topic. More resources.

Key stats and trends about this topic

Featuring the top 3 experts for this topic

Advertisement

Share via Email

Share this WisdomCard with others by embedding on your site or blog.

300x260

425x300

560x390